The effect of lavender and clotrimazole in the treatment of vaginal candidiasis

Phase 3

• Conditions: candidiasis.; Candidiasis of vulva and vagina; B37.3+

• Registration Number: IRCT138902103004N3
• Lead Sponsor: Babol university of medical sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

15 to 49 years old married women. Exclusion criteria: women that had history of using antibiotic, oral contraceptive pills, any antifungal drugs, for 4 weeks before the study, latescent or pregnant women ,using immunosuppressive drugs, have cervicitis sign and cervix ectropion, Trichomoniasis and bacterial vaginosis, overweight (Body Mass Index>29) and have diabetes

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement of candidiasis signs. Timepoint: 4-7 next days. Method of measurement: Examination & labratory test & questionnaire.

Secondary Outcome Measures

Name	Time	Method
Recurrence of disease improvment. Timepoint: 40 next days. Method of measurement: Examination & labratory test & questionnaire.